This opportunity is no longer accepting applications.
grant PAS-22-096

Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)

The SHINE program supports innovative, high-quality research in nonmalignant hematology, aligning with the NIDDK, NIA, and NHLBI missions. It invites R01 grant applications for basic and early translational research projects in this field. The focus topics evolve over time and are updated annually through the NIH Guide to Grants and Contracts.

The Stimulating Hematology Investigation: New Endeavors (SHINE) program is intended to promote innovative, high-quality nonmalignant hematology research relevant to the missions of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Aging (NIA), a…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Diabetes and Digestive and Kidney Diseases
Program: SBIR

Dates

Opportunity Released: December 22, 2021
Open for Submission: December 22, 2021
Submission Deadline: January 7, 2025
Application Window Closes: January 7, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.